pyrroles has been researched along with sitagliptin phosphate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhome, R; Penn, H | 1 |
| Scheen, AJ | 1 |
| Aquilante, CL; Kosmiski, LA; Predhomme, JA; Sidhom, MS; Wempe, MF | 1 |
| Ibrahim, SSA; Salama, MA; Selima, E; Shehata, RR | 1 |
1 review(s) available for pyrroles and sitagliptin phosphate
| Article | Year |
|---|---|
Pharmacokinetic evaluation of atorvastatin and sitagliptin in combination for the treatment of type 2 diabetes.
Topics: Atorvastatin; Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrazines; Pyrroles; Risk Assessment; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2012 |
1 trial(s) available for pyrroles and sitagliptin phosphate
| Article | Year |
|---|---|
Effect of ABCB1 polymorphisms and atorvastatin on sitagliptin pharmacokinetics in healthy volunteers.
Topics: Adult; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Cohort Studies; Colorado; Cross-Over Studies; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Genetic Association Studies; Half-Life; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Clearance Rate; Middle Aged; Polymorphism, Single Nucleotide; Pyrazines; Pyrroles; Sitagliptin Phosphate; Triazoles; Young Adult | 2013 |
2 other study(ies) available for pyrroles and sitagliptin phosphate
| Article | Year |
|---|---|
Rhabdomyolysis precipitated by a sitagliptin-atorvastatin drug interaction.
Topics: Aged; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; Humans; Male; Pyrazines; Pyrroles; Rhabdomyolysis; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2012 |
Sitagliptin and tofacitinib ameliorate adjuvant induced arthritis via modulating the cross talk between JAK/STAT and TLR-4/NF-κB signaling pathways.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Blood Glucose; Drug Synergism; Drug Therapy, Combination; Hypoglycemic Agents; Interleukin-6; Janus Kinases; Lipids; Male; NF-kappa B; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Signal Transduction; Sitagliptin Phosphate; STAT Transcription Factors; STAT3 Transcription Factor; Toll-Like Receptor 4 | 2020 |